Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 21.09.2026 1 BMJ 1 J Infect 3 J Infect Dis 1 J Pediatr 1 Nat Med 1 Pediatr Infect Dis J 1 PLoS Comput Biol 5 PLoS One 19 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. WILLMAN D
   US officials knew covid vaccine safety system was flawed-but turned aside the FDA doctor who alerted them.
   BMJ. 2026;394:e100806.
   PubMed        
   
   

   
   J Infect

2. HARRIS R, Thirard R, Iftikhar H, Middleditch A, et al
   Corrigendum to "Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial" [J Infect 93 (2026) 106784].
   J Infect. 2026;93:106853.
   PubMed        
   
   

   
   J Infect Dis

3. LEWIS RM, Naleway AL, Henninger ML, Panicker G, et al
   HPV antibody concentrations among male and female adolescents after single-dose 9-valent HPV vaccination.
   J Infect Dis. 2026 Sep 19:jiag476. doi: 10.1093.
   PubMed         Abstract available
   
   
4. JOHN M, Ge Y, Billings WZ, Miller SL, et al
   Impact of dose on norovirus antibody kinetics following infection or vaccination.
   J Infect Dis. 2026 Sep 19:jiag474. doi: 10.1093.
   PubMed         Abstract available
   
   
5. GEROPEPPA M, Papadatou I, Verrou KM, Lembessis P, et al
   Systems analysis of immunity to pneumococcal vaccination in preterm and full term infants.
   J Infect Dis. 2026 Sep 18:jiag473. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Pediatr

6. CHEUNG A, Jain A, Bernstein S, Sarathy L, et al
   Respiratory Syncytial Virus Immunization Disparities in Mothers and Infants at the Birth Hospitalization: A Cross-Sectional Study.
   J Pediatr. 2026 Jul 2:115219. doi: 10.1016/j.jpeds.2026.115219.
   PubMed         Abstract available
   
   

   
   Nat Med

7. CHEN S, Bento AI
   County, district and community-level measles transmission in the United States in 2013-2025.
   Nat Med. 2026;32:3181-3191.
   PubMed         Abstract available
   
   

   
   Pediatr Infect Dis J

8. PLOTKIN SA
   The Way Forward With Pertussis Vaccination.
   Pediatr Infect Dis J. 2026 Sep 14. doi: 10.1097/INF.0000000000005403.
   PubMed        
   
   

   
   PLoS Comput Biol

9. D'AVANZO M, Myint AP, Cacciapaglia G, Hohenegger S, et al
   From sequences to strategies: Early detection of new SARS-CoV-2 variants via genetic distance to reduce hospitalizations.
   PLoS Comput Biol. 2026;22:e1014707.
   PubMed         Abstract available
   
   

   
   PLoS One

10. OLANI A, Bayisa G, Chala M, Gurmessa L, et al
    Assessment of vaccination competency among health workers in health facilities in East Wollega, Oromia, Western Ethiopia: An observational study.
    PLoS One. 2026;21:e0358136.
    PubMed         Abstract available
    
    
11. ALAM NF, Chakrabarty M, Debnath T, Sheikh MA, et al
    Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches.
    PLoS One. 2026;21:e0357758.
    PubMed         Abstract available
    
    
12. WOLSKO C, Marino E
    Incorporating public values into public health communications: Effects of value affirmations on intentions to vaccinate and trust in the U.S.
    PLoS One. 2026;21:e0356783.
    PubMed         Abstract available
    
    
13. SINGHATEH Y, Matoko TM, Shaabe M, Maepe SA, et al
    Progress towards measles and rubella elimination in Lesotho, 2011-2025.
    PLoS One. 2026;21:e0358555.
    PubMed         Abstract available
    
    
14. GWANZURA TNR, Trepka MJ, Li T, Juhasz L, et al
    COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study.
    PLoS One. 2026;21:e0358543.
    PubMed         Abstract available
    
    

    
    Vaccine

15. NAKAO R, Uchiyama H, Yamaguchi T, Abe K, et al
    A mucosal prime-systemic boost strategy using a glycoengineered bacterial membrane vesicle vaccine elicits protective mucosal immunity against pneumococci in mice.
    Vaccine. 2026;92:129142.
    PubMed         Abstract available
    
    
16. AREDE M, Brandstetter S, Beyerlein A, Kabesch M, et al
    Coverage and adherence to the German childhood vaccination schedule: results from the KUNO-Kids health study.
    Vaccine. 2026;92:129164.
    PubMed         Abstract available
    
    
17. ZHOU B, Wang J, Knote C
    Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression.
    Vaccine. 2026;92:129163.
    PubMed         Abstract available
    
    
18. FORR A, Salmon DA, Markalanda SH, Joseph A, et al
    Promoting a personalized vaccine information website through social media and local outreach: a dissemination and implementation study.
    Vaccine. 2026;92:129161.
    PubMed         Abstract available
    
    
19. OSTROWSKY JT, Gellin BG, Cavaleri M, Bresee JS, et al
    Innovation, development, and licensure of improved influenza vaccines: the way forward.
    Vaccine. 2026;92:129135.
    PubMed         Abstract available
    
    
20. OOSTVOGELS L, Alhatemi A, De Gussem S, Englev E, et al
    A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75.
    Vaccine. 2026;92:129133.
    PubMed         Abstract available
    
    
21. BLANCHARD C, Myers J, McNabb AL, Lee YA, et al
    Evaluating access to COVID-19 vaccines for children and adolescents in North Carolina through community pharmacies, 2021-2023.
    Vaccine. 2026;92:129125.
    PubMed         Abstract available
    
    
22. HOEN L, Lartey S, Pathirana RD, Cox RJ, et al
    Elucidating the role of pre-existing immunity in mucosal lymphoid architectural dynamics following live attenuated influenza vaccination.
    Vaccine. 2026;92:129139.
    PubMed         Abstract available
    
    
23. GUO J, Dai C, Huang Y, Dai J, et al
    Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys.
    Vaccine. 2026;92:129137.
    PubMed         Abstract available
    
    
24. KAISER TJ, Jarrett A, Johnson W, Hinds M, et al
    Evaluation of the efficacy and duration of immunity of a bivalent subunit vaccine containing porcine circovirus type 2a and type 2d antigen.
    Vaccine. 2026;92:129159.
    PubMed         Abstract available
    
    
25. POLANIA-ESPINOSA D, Salgado D, Vega R, Castaneda-Uvajoa D, et al
    Vaccine- and infection-induced pneumococcal and DENV-NS1 antibodies reveal differential transplacental transfer and maternal-infant early exposure burden.
    Vaccine. 2026;92:129138.
    PubMed         Abstract available
    
    
26. VAN VREESWIJK-VAN DONSELAAR L, Bosma L, Zemouri C, Hoogsteder M, et al
    Maternal pertussis vaccination uptake and reasons for non-vaccination among pregnant women in the Netherlands: a 5-year retrospective cohort study.
    Vaccine. 2026;92:129101.
    PubMed         Abstract available
    
    
27. LI M, Yuan D, Wang Z, Xuan Y, et al
    Impact of different MMR vaccination strategies on mumps incidence in Jiangsu, China: A 20-year interrupted time series analysis based on 180,000 cases.
    Vaccine. 2026;92:129156.
    PubMed         Abstract available
    
    
28. MUNOZ A, Gagneux-Brunon A, Le Duc-Banaszuk AS, Bruel S, et al
    Which changes in adolescents' knowledge, attitudes, and practices following a school-based intervention in France increase HPV vaccination uptake and intentions? A mediation analysis.
    Vaccine. 2026;92:129150.
    PubMed         Abstract available
    
    
29. SBARRA AN, Mutembo S, Carcelen A, Prosperi C, et al
    Multi-pathogen serosurveillance reveals correlated vaccination performance, waning tetanus immunity, and diphtheria boosting in Zambian children.
    Vaccine. 2026;92:129160.
    PubMed         Abstract available
    
    
30. CORDOBA-SANCHEZ V, Lemos M, Gaviria-Gomez AM, Sheinfeld Gorin S, et al
    A cluster-randomized trial of the school-based 'Superprotegidas' behavioral intervention to improve HPV vaccination uptake in Colombian girls.
    Vaccine. 2026;92:129172.
    PubMed         Abstract available
    
    
31. LAOHARATTANAHIRUN N, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
    Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.
    Vaccine. 2026;92:129166.
    PubMed         Abstract available
    
    
32. ILIYASU Z, Abubakar MS, Iliyasu BZ, Nass NS, et al
    Safety first, science second: Healthcare workers' conditional trust and willingness to participate in Lassa fever vaccine trials in Nigeria.
    Vaccine. 2026;92:129162.
    PubMed         Abstract available
    
    
33. SASAKI T, Masuda A, Lee JM, Tamiya S, et al
    Immunogenicity of norovirus VP1-expressing silkworm (Bombyx mori) pupae as an edible vaccine candidate.
    Vaccine. 2026;92:129108.
    PubMed         Abstract available
    
    

    
    Virus Res

34. ZHENG YT, Jin XZ, Zhang CJ, Chen SS, et al
    An IMS 1313-Based Inactivated PRV Vaccine with a novel immunopotentiator induces Robust Protective Immunity against Virulent Variants.
    Virus Res. 2026 Sep 14:199801. doi: 10.1016/j.virusres.2026.199801.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum